Biologics

At the forefront of regenerative medicine, our biologics represent the next generation of healing. From amniotic tissue and placental membranes to exosome-rich serums and PRP solutions, we offer a curated line of advanced therapies designed to accelerate repair, reduce inflammation, and restore function at the cellular level. These powerful tools are trusted by leading practitioners across multiple specialties—wound care, orthopedics, aesthetics, neurology, and more—to support natural healing and improve patient outcomes.

Kurve

the future of medicine is here

Learn More

Stem cells and exosomes hold immense potential to reverse aging, repair tissue, and reduce inflammation—but delivery matters. Traditional IV therapy often results in less than 1% of biologics reaching the brain due to the blood-brain barrier.

The Kurve ViaNase® device changes that.

Using patented Controlled Particle Dispersion® (CPD) technology, Kurve delivers biologics through the upper nasal cavity—bypassing the blood-brain barrier and achieving up to 40% direct absorption into the central nervous system. Backed by 20+ clinical trials, including studies in Alzheimer’s and Parkinson’s, it’s a breakthrough in non-invasive, targeted brain therapy.

When combined with biologics, Kurve opens a new era in neuroregeneration and anti-aging care.

GENESIS® REGENERATIVE PROTEIN ARRAY

Genesis RPA is a next-generation regenerative biologic uniquely formulated with miRNA, growth factors, and cytokines derived from all three layers of the placenta — mesoderm, endoderm, and ectoderm. This comprehensive protein array supports the healing and regeneration of musculoskeletal (MSK), neurological, nerve, soft tissue, and internal organ systems.

While many regenerative treatments source proteins from just one layer of placental tissue—limiting their applications primarily to MSK conditions—Genesis RPA is designed to support full-body healing and help restore the body to homeostasis.

Genesis RPA is exempt from 21 CFR 1271 biologic regulations, thanks to its proprietary 30-day incubation process. Unlike traditional products that require extraction or destruction of placental tissue, Genesis RPA captures naturally emitted bioactive factors—a unique “cell factor” approach.

The FDA oversees donor screening, production, endotoxin testing, lyophilization, and packaging, ensuring quality and safety.

However, the final product is treated as a nutraceutical, empowering you and your patients to decide if it’s the right fit for their personalized care journey.

Downloads

Biologics

We source the highest-quality biologics — including stem cells, exosomes, amniotic membranes, and growth factors — from FDA-registered and rigorously vetted labs across the country. These industry-leading laboratories adhere to the highest standards of safety, purity, and clinical efficacy.

Biologics Available

  • Cord Blood Stem Cells
    Rich in hematopoietic and mesenchymal stem cells, used for immune modulation and tissue repair.

  • Cord Blood Exosomes
    Nano-sized vesicles from cord blood that promote cellular regeneration and communication.

  • Wharton’s Jelly
    A gelatinous substance in the umbilical cord, rich in mesenchymal stem cells ideal for orthopedic and soft tissue repair.

  • Wharton’s Jelly Exosomes
    Combines the regenerative power of Wharton’s Jelly with exosome delivery for targeted cellular repair.

  • Amniotic Exosomes
    Derived from amniotic fluid, these exosomes deliver growth factors and cytokines for advanced healing.

  • Amniotic Allografts for Chronic Wounds
    Biologic tissue grafts that promote wound closure and regeneration in chronic, non-healing wounds.

  • Lyophilized Exosomes with Peptides
    Freeze-dried for extended shelf life, this formulation enhances repair with exosomes and bioactive peptides.

TESTIMONIALS

What Are Our Customers Saying ?

"As a physician with over 20 years of experience, I’ve never seen such transformative results until I began using the regenerative products and systems provided by this team. The quality of the biologics — from exosomes to stem cells — is unmatched, and the integration of advanced equipment like red light therapy and PEMF has taken my patient outcomes to another level. What sets them apart is not just the products, but the support behind them. From clinical training to business strategy, they’ve helped streamline my practice and elevate the care I provide. This isn’t the future of medicine — it’s happening now."

Small Call to Action Headline

DR. Drucker

Get In Touch